Castlerock Asset Management’s Trinity Biotech TRIB Stock Holding History

Castlerock Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$489K	Buy	+178	New	+$578K	4.12%	10

Other funds holding TRIB

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

Lyon Street Capital Sausalito, California $67M AUM

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

William Blair & Company

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Castlerock Asset Management's TRIB Position: Q3 2014 in Review

Castlerock Asset Management opened a new position in Trinity Biotech (TRIB) in Q3 2014: 178 shares worth $489K. The stake represents 4.12% of the portfolio and ranks #10 among its holdings.

93 funds tracked by Wall St. Rank hold TRIB as of Q3 2014.

Castlerock Asset Management held 178 shares of Trinity Biotech worth $489K as of Q3 2014.
Trinity Biotech was a new Castlerock Asset Management position in Q3 2014.
Trinity Biotech made up 4.12% of Castlerock Asset Management's portfolio in Q3 2014, its #10 holding.
93 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2014.

Based on Castlerock Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.